Home
About Us
At a Glance
Our History
Leadership
Our Facilities
Our Business Model
Overview
Our Business Lines
Our Strengths
Our Strategy
Investor Relations
Sustainability
Overview
Environmental Leadership
Our People
Health & Safety
Governance
Code of Conduct
Media
News
Videos
Contact Us
Safety Report
Home
About Us
At a Glance
Our History
Leadership
Our Facilities
Our Business Model
Overview
Our Business Lines
Our Strengths
Our Strategy
Investor Relations
Sustainability
Overview
Environmental Leadership
Our People
Health & Safety
Governance
Code of Conduct
Media
News
Videos
Contact Us
Safety Report
Vatorprix 35
Home
/
Vatorprix 35
Category
Cardiovascular
About This Project
Product Description
Fenofibric acid 35 mg
(30 tablets)
Therapeutic category
Cardiovascular
Dosage form
One tablet once daily
